Hosted on MSN
Tactile projects 8%–10% revenue growth for 2025 as airway clearance momentum accelerates
Earnings Call Insights: Tactile Systems Technology, Inc. (TCMD) Q3 2025 The company raised 2025 total revenue guidance to $317 million to $321 million, with lymphedema products expected to grow 3% to ...
Hosted on MSN
Tactile Systems outlines 2025 revenue guidance of $310M-$315M while strengthening airway clearance growth
Earnings Call Insights: Tactile Systems Technology, Inc. (TCMD) Q2 2025 CEO Sheri Louise Dodd reported "a strong performance this quarter, marked by total revenue growth of 7.8% year-over-year to ...
JERSEY CITY, N.J. and OR YEHUDA, Israel, Oct. 8, 2025 /PRNewswire/ -- Synchrony Medical, a medical technology company dedicated to transforming respiratory care, announced today the launch of its ...
JERSEY CITY, N.J. and OR YEHUDA, Israel, Jan. 12, 2026 /PRNewswire/ -- Synchrony Medical, a respiratory care technology company and creator of the FDA-cleared LibAirty™ airway clearance system, today ...
The company raised 2025 total revenue guidance to $317 million to $321 million, with lymphedema products expected to grow 3% to 4% and airway clearance products 52% to 55%. Birkemeyer stated, "Our ...
For the full year 2025, CFO Birkemeyer reported, "we now expect total revenue in the range of $310 million to $315 million, representing growth of approximately 6% to 8% year-over-year." The guidance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results